People In Brief
This article was originally published in The Gray Sheet
Executive Summary
New leader at NDO Surgical: Bernard Haffey assumes the helm of NDO Surgical as CEO, effective April 10. Haffey will help elevate commercial adoption of and improve reimbursement for NDO's Plicator endoscopic suturing technology for the treatment of gastroesophageal reflux disease. The new chief will draw on his experience in bringing early-stage medical devices to market, most recently as chief commercial officer at laser vision technology maker IntraLase, which was recently acquired by Advanced Medical Optics (1"The Gray Sheet" Jan 15, 2007, p. 4). Prior to IntraLase, Haffey served as CEO at NeuroVision, as well as executive VP and chief commercial officer at Summit Autonomous, which was acquired by Alcon Laboratories in 2000. NDO Surgical also brings on John Frantzis as VP-global sales and business development. Frantzis carries 25 years high-tech and medical device management experience, most recently as VP-sales and business development at ocular biometric firm Retica. NDO Surgical is conducting animal trials for a sleeve gastroplasty device on the Plicator platform to treat obesity...
You may also be interested in...
AMO Cites Marketing, R&D Synergies Of $808 Mil. IntraLase Acquisition
Advanced Medical Optics will market its wavefront-guided excimer laser system and IntraLase's laser keratome together as a unique "all-laser" LASIK vision correction system following the merger of the two companies
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.